Images List Premium Download Classic

Cardiovascular Disease

Cardiovascular Disease-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Lipoprotein analysis by differential charged-particle mobility
Quest Diagnostics Investments Incorporated
January 11, 2018 - N°20180011117

The invention provides methods of preparation of lipoproteins from a biological sample, including hdl, ldl, lp(a), idl, and vldl, for diagnostic purposes utilizing differential charged particle mobility analysis methods. Further provided are methods for analyzing the size distribution of lipoproteins by differential charged particle mobility, which lipoproteins are prepared by methods of the invention. Further provided are methods for ...
Lpl/rlp for assessment of cardiovascular disease risk
True Health Diagnostics, Llc
January 11, 2018 - N°20180011094

In various embodiments, the application relates to methods for assessment of cardiovascular disease (cvd) risk in a patient comprising comparing pre-heparin lpl (lipoprotein lipase) levels which are associated with protection from cvd to remnant lipoprotein cholesterol (rlp-c) and/or remnant lipoprotein triglyceride content (rlp-tg).
Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
The Regents Of The University Of California
January 11, 2018 - N°20180010148

In alternative embodiments, the invention provides methods for treating, ameliorating or protecting (preventing) an individual or a patient against a disease, an infection or a condition responsive to an increased paracrine polypeptide level in vivo comprising: providing a paracrine polypeptide-encoding nucleic acid or gene operatively linked to a transcriptional regulatory sequence; or an expression vehicle, a vector, a recombinant virus, ...
Cardiovascular Disease Patent Pack
Download 215+ patent application PDFs
Cardiovascular Disease Patent Applications
Download 215+ Cardiovascular Disease-related PDFs
For professional research & prior art discovery
inventor
  • 215+ full patent PDF documents of Cardiovascular Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel diagnostic and therapeutic target in inflammatory and/or cardiovascular diseases
University Of Zurich
January 11, 2018 - N°20180009907

Methods for diagnosing inflammatory and/or cardiovascular diseases by assaying for fibroblast activation protein (fap) expression in a body fluid is provided as well as therapeutic means based thereon.
Heterocyclic compounds as pi3k-y inhibitors
University Of Zurich
January 11, 2018 - N°20180009816

Or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of pi3k-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
Inhibitors of the renal outer medullary potassium channel
Merck Sharp & Dohme Corp.
January 11, 2018 - N°20180009807

The present invention provides compounds of formula i (i) and the pharmaceutically acceptable salts thereof, which are inhibitors of the romk (kir1. 1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive ...
Cardiovascular Disease Patent Pack
Download 215+ patent application PDFs
Cardiovascular Disease Patent Applications
Download 215+ Cardiovascular Disease-related PDFs
For professional research & prior art discovery
inventor
  • 215+ full patent PDF documents of Cardiovascular Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel uses
Intra-cellular Therapies, Inc.
January 04, 2018 - N°20180000825

The invention relates to the administration of inhibitors of phosphodiesterase 1 (pde1) for the treatment of diseases or disorders characterized by disruption of or damage to various cgmp/pkg mediated pathways. In one embodiment the invention relates to inhibitors of phosphodiesterase 1 (pde1) for treatment of cardiovascular disease and related disorders, e. G., congestive heart disease, atherosclerosis, myocardial infarction, and stroke.
Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and hmg coa ...
Dezima Pharma B.v.
January 04, 2018 - N°20180000818

The present invention relates to a pharmaceutical composition and a therapeutic combination comprising a novel cholesteryl ester transfer protein (cetp) inhibitor and a hmg coa reductase inhibitor, which may be used in the treatment of subjects suffering from or having an increased risk for cardiovascular diseases, in particular hyperlipidemia or mixed dyslipidemia.
Compositions and methods for treating cardiovascular diseases
Infirst Healthcare Limited
January 04, 2018 - N°20180000763

The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a cardiovascular disease in an individual using such pharmaceutical compositions.
Cyclodextrin-based polymers for therapeutic delivery
Cerulean Pharma Inc.
December 28, 2017 - N°20170368194

Provided are methods relating to the use of cdp-therapeutic agent conjugates for the treatment of a disease or disorder, e. G., autoimmune disease, inflammatory disease, central nervous system disorder, cardiovascular disease, or metabolic disorder. Also provided are cdp-therapeutic agent conjugates, particles comprising cdp-therapeutic agent conjugates, and compositions comprising cdp-therapeutic agent conjugates.
Diagnostics and therapeutics for diseases associated with g-protein coupled receptor adipor2 (adipor2)
Siemens Healthcare Diagnostics Inc.
December 28, 2017 - N°20170368171

The invention provides human adipor2 which is associated with the cardiovascular diseases, dermatological diseases, gastroenterological diseases, cancer, hematological diseases, respiratory diseases, inflammation, neurological diseases, urological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases, dermatological diseases, gastroenterological diseases, cancer, hematological diseases, respiratory diseases, inflammation, neurological diseases, urological diseases. The ...
Adenylyl cyclase inhibitors, pharmaceutical compositions and method of use thereof
Siemens Healthcare Diagnostics Inc.
December 21, 2017 - N°20170362235

Wherein x, l, r1, r2, r5 are those defined herein. Compounds of the present invention are useful to treat cardiovascular diseases. The present invention also relates to a method of preventing heart failure by administering an effective amount of compound according to the invention following vascular injury and reperfusion therapy.
Substituted bridged urea analogs as sirtuin modulators
Glaxosmithkline Intellectual Property (no.2) Limited
December 21, 2017 - N°20170362234

The present invention relates to novel substituted bridged urea analog compounds of formula (i) or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, processes for making and use of such compounds, alone or in combination with other therapeutic agents, as sirtuin modulators useful for increasing lifespan of a cell, and in treating and/or preventing a wide variety of diseases and ...
Cardiovascular Disease Patent Pack
Download 215+ patent application PDFs
Cardiovascular Disease Patent Applications
Download 215+ Cardiovascular Disease-related PDFs
For professional research & prior art discovery
inventor
  • 215+ full patent PDF documents of Cardiovascular Disease-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Cardiovascular disease treatment and prevention
Transdermal Biotechnology, Inc.
December 21, 2017 - N°20170360944

The present invention generally relates to compositions and methods for treatment of subjects having or at risk of arteriosclerosis, hypertension, sickle-cell anemia, or other conditions. In some cases, the composition may include nitric oxide, peptides, or both. The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the ...
Neuregulin based methods and compositions for treating cardiovascular diseases
Zensun (shanghai) Science & Technology, Co., Ltd.
December 21, 2017 - N°20170360889

The present invention relates to compositions and methods for preventing, treating or delaying various cardiovascular diseases or disorders in mammals, particularly in humans. More particularly, the present invention provides for compositions and methods for preventing, treating or delaying various cardiovascular diseases or disorders using, inter alia, a neuregulin protein, or a functional fragment thereof, or a nucleic acid encoding a ...
Methods for the treatment of polycystic ovary syndrome
Center For Reproducitive Medicine, Shandong Provincial Hospital, Shandong University
December 21, 2017 - N°20170360843

Polycystic ovary syndrome (pcos) is a complex and heterogeneous endocrine syndrome associated with a high risk for the development of insulin resistance, type 2 diabetes (t2d), obesity, dyslipidemia, and cardiovascular disease. There are no known therapies for the 9-18% of women afflicted with pcos. Provided herein are methods for the treatment and/or prevention of at least one symptom of ...
Compositions and methods for the prevention and treatment of cardiovascular diseases
Reven Pharmaceuticals Inc.
December 21, 2017 - N°20170360696

Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided.
Method for predicting response to continuous positive air pressure treatment
Centro De Investigacion Biomedica En Red
December 14, 2017 - N°20170356046

An in vitro method predicts the response to continuous positive airway pressure (cpap) in a subject in need thereof. The method includes determining in an isolated sample of the subject the level of expression of a cardiovascular system functionally related microrna differentially expressed in patients with cardiovascular disease. The microrna is selected from the group: mir. 100. 5p, mir. 378a. 3p, ...
Metabolically stable apelin analogs in the treatment of disease mediated by the apelin receptor
Universite De Strasbourg
December 14, 2017 - N°20170355734

The invention is related to metabolically stable apelin analogs and their use for the prevention or the treatment of diseases mediated by the apelin receptor in particular of cardiovascular disease (heart failure, hypertension, pulmonary hypertension, kidney failure) and inappropriate vasopressin secretions (siadh).
Substituted bridged urea analogs as sirtuin modulators
Glaxosmithkline Intellectual Property (no.2) Limited
December 14, 2017 - N°20170355705

The present invention relates to novel substituted bridged urea analog compounds of formula (i) or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, processes for making and use of such compounds, alone or in combination with other therapeutic agents, as sirtuin modulators useful for increasing lifespan of a cell, and for use in treating and/or preventing a wide variety of ...
Substituted bridged urea analogs as sirtuin modulators
Glaxosmithkline Llc
December 14, 2017 - N°20170355697

The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders ...
Loading